In order to replicate previous published results we examined the CSF-NFL levels of HD patients (participating in a clinical trial SAT-HD), compared the results with a sample of healthy controls and correlated CSF-NFL levels with demographic and clinical variables (baseline demographic characteristics and HD measures of disease severity). The gene discussed is NEFL; the disease is Huntington disease.